Ernst Ulsperger

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Thomas Brodowicz, Maciej Krzakowski, Matjaž Zwitter et al. · Lung Cancer · 2006 · 323 citations

Medicine, Oncology, Pharmacology +13

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Luis Paz‐Ares, J. Mezger, Tudor–Eliade Ciuleanu et al. · The Lancet Oncology · 2015 · 131 citations · Full text

Medicine, Oncology, Pharmacology +13

The impact of extracellular matrix on the chemoresistance of solid tumors – experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy

Gerhard Baumgartner, Ch Gomar-Höss, Lama Sakr et al. · Cancer Letters · 1998 · 123 citations

Medicine, Oncology, Pharmacology +17

Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance

Lukas Klameth, Barbara H. Rath, Maximilian Hochmaier et al. · Scientific Reports · 2017 · 85 citations · Full text

Medicine, Cancer Biology, Cell Biology +16

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer

Christian Manegold, Johan Vansteenkiste, Felipe Cardenal et al. · Investigational New Drugs · 2012 · 63 citations · Full text

Medicine, Oncology, Pharmacology +13